share_log

Sangamo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Smith Karen L.

SEC announcement ·  Jun 6 16:34
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more